Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Functional interaction between B cell subpopulations defined by CD23 expression.

R J Armitage1, L K Goff

  • 1I.C.R.F. Human Tumor Immunology Group, Courtauld Institute of Biochemistry, London, GB.

European Journal of Immunology
|November 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma.

Leukemia·2005
Same author

Increase in the ratio of mitochondrial Bax/Bcl-XL induces Bax activation in human leukemic K562 cell line.

Apoptosis : an international journal on programmed cell death·2004
Same author

High level amplification of N-MYC is not associated with adverse histology or outcome in primary retinoblastoma tumours.

British journal of cancer·2002
Same author

Modelling the human immune response: can mice be trusted? Commentary.

Current opinion in pharmacology·2001
Same author

Phase I study of recombinant human CD40 ligand in cancer patients.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Same author

Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Same journal

Special Issue: yEFIS 3rd Symposium.

European journal of immunology·2026
Same journal

CRISPR/Cas9-Mediated Gene Knockout Reveals a Nonredundant Role for p16<sup>INK4A</sup> in Controlling TCR-Dependent and Independent CD8 T Cell Expansion.

European journal of immunology·2026
Same journal

Induction of Humoral and Cellular Immunity After SARS-CoV-2 JN.1 Vaccination in Individuals With and Without Prior Infection.

European journal of immunology·2026
Same journal

Complement in Traumatic Brain Injury: Linking Acute Injury to Chronic Neurodegeneration.

European journal of immunology·2026
Same journal

Shifting From Systemic to Precision-Targeted Complement Therapies: Opportunities and Hurdles.

European journal of immunology·2026
Same journal

Methodological Insights Into T-Cell Activation: CD3/CD28 Versus PMA/Ionomycin Stimulation.

European journal of immunology·2026
See all related articles

This study reveals a novel interaction between normal B cells expressing CD23 (MHM6+) and those not expressing it (MHM6-), crucial for B cell proliferation. This interaction is absent in prolymphocytic leukemia B cells, highlighting a key difference in immune regulation.

Area of Science:

  • Immunology
  • Cell Biology
  • Hematology

Background:

  • CD23 is a molecule expressed on B cells, with its expression levels changing upon cell activation.
  • Understanding B cell activation and proliferation is crucial for immunology and hematology research.
  • Previous studies have indicated varied roles for CD23 in B cell function.

Purpose of the Study:

  • To investigate the functional significance of CD23 expression levels on tonsil B cell proliferation.
  • To elucidate the interaction between CD23-positive (MHM6+) and CD23-negative (MHM6-) B cell populations.
  • To compare the CD23-mediated interactions in normal B cells versus prolymphocytic leukemia (PLL) B cells.

Main Methods:

  • Purification of MHM6+ and MHM6- tonsil B cells using magnetic beads and CD23 monoclonal antibody (mAb) MHM6.

Related Experiment Videos

  • Assessment of B cell proliferation in response to various mitogenic stimuli, including anti-IgM, IL-4, CDw40 mAb G28-5, SAC, and TPA.
  • Analysis of cell contact dependency and the role of soluble factors in B cell proliferation, including soluble CD23 and anti-leukocyte functional antigen 1 mAb.

    • Main Results:

    • Increased CD23 expression on activated B cells results from antigen upregulation, not de novo expression.
    • MHM6+ cells exhibit strong proliferative responses, while MHM6- cells show weak responses alone but are augmented by MHM6+ cells via cell contact and soluble factors.
    • Soluble CD23 enhances MHM6- cell proliferation in the presence of MHM6+ cells.
    • Prolymphocytic leukemia (PLL) B cells, unlike normal B cells, show strong proliferative responses independent of MHM6+ cell interaction and do not upregulate CD23 upon activation.

    Conclusions:

    • A novel, contact-dependent and soluble factor-mediated functional interaction exists between normal MHM6+ and MHM6- B cell populations.
    • This CD23-mediated interaction is essential for optimal proliferation of normal B cells but is absent in prolymphocytic leukemia B cells.
    • The findings suggest a critical role for CD23 in regulating normal B cell activation and highlight a potential difference in immune regulation in B cell malignancies.